MSF: It is urgent to release the patent for the vaccine against COVID-19 | Coronavirus | DW

The hoarding of vaccines, the lack of local production and transparency by pharmaceutical companies have marked the beginning of global vaccination. While some countries have acquired five times more doses than they require for their population, others do not have a guaranteed dose. Around the world, the lack of vaccines translates into seriously ill people and deaths.

The humanitarian organization Doctors Without Borders (MSF) supports a petition to release patents and achieve mass vaccination. In conversation with DW, Josefina Martorell, its general director for Spanish-speaking South America, exhorts to put public health above economic interests.

DW: A few months after the start of vaccination against COVID-19, inequality is the central issue, countries with higher incomes have more vaccines than the rest. Is it necessary to release patents?

Josefina Martorell: That’s right, at Médecins Sans Frontières we support a petition that India and South Africa have submitted to the World Trade Organization (WTO) to temporarily suspend patents on COVID-19 medical tools, including vaccines, diagnoses and treatment until achieve herd immunity. It can be found at www.msf.org.ar/patentes.

What is the problem today in vaccine production?

Very few laboratories control vaccines, decide prices, quantities and delivery times. They cannot produce enough to meet global demand, and there are shortages, especially in low- and middle-income countries.

At MSF they are well aware of the importance of vaccination, what is the risk of not achieving it in the short term?

Variants will continue to be developed and some vaccines will not be effective. Then other forms of this COVID-19 pandemic will appear. At the level of utilitarianism, what is in our best interest throughout the world is for the pandemic to end everywhere; otherwise it won’t end for anyone.

Josefina Martorell.

Have any patents been released before?

This pandemic is an exception and justifies it. A similar suspension was applied at the beginning of the HIV / AIDS epidemic to give low-income countries the possibility of adopting drugs. This negotiation took place over a period of time and helped millions of people.

Which governments have supported the release of patents?

There are more than 100 countries that have supported the petition around the world; others are against it, for example, in the region, the United States and Brazil. However, we believe that this can be achieved, as each country represents one vote before the WTO. At the moment there are discussions and the decision would be made in March.

What if high-income countries vote against it?

If the patent would be opened, what they can do is that it continues to be protected in their own country. Some vaccines use more advanced technologies, which prevents some countries from producing them. In other vaccines against COVID-19 it is only necessary to know the formula and local companies can produce it. This is not against pharmaceutical companies; They will be able to continue producing it and already have a competitive advantage, they have even signed contracts with governments. They have won and will continue to win.

COVAX was intended as a global equitable access fund for vaccines. What happened?

At the moment (02.22.2021) it will have access to only 2% of everything that Pfizer will produce and it is to be distributed among 145 countries. It is an option for low-income countries, but all countries have applied to be part. As a result we see dysfunctional situations, where high-income countries are requesting vaccines from the mechanism, although they already have five times more than the doses they require for their population.

Press picture Medecins sans Frontiers South America

MSF reaches far away places with supplies to fight the pandemic.

What has been the work of Doctors Without Borders during the pandemic?

We continue to work around the world with more than 450 projects, plus work with COVID-19. In the region we are in Mexico, Salvador, Honduras, Nicaragua, Venezuela, Colombia. We have also opened emergency missions in Peru and Ecuador due to the high contagion and lethality in the most vulnerable areas where access to medical care is low. We work in Manaus, Brazil, as it is the gateway to the Amazon region and last year the contagion began, which spread to several remote regions where indigenous communities live and with catastrophic consequences.

Has the pandemic been the biggest challenge the organization has ever faced?

It has been one of the most important, so is Ebola, which is now returning with an outbreak in Guinea. That worries us a lot. The pandemic required us to readjust, because in a natural catastrophe or even during Ebola, our staff and supplies arrive at the scene within 48 hours. With COVID-19 we were limited by closed borders, especially in the first months.

.

La Jornada – Brazilian nurse charged with false vaccination against Covid

Rio de Janeiro. The Justice of Rio de Janeiro on Monday accepted a complaint from the Prosecutor’s Office against the nursing technician Rozemary Gomes Pita, accused of a crime against public health for a false vaccination against Covid-19 in Niteroi (state of Rio de Janeiro, southeast from Brazil).

Judge Daniela Barboza de Souza decided to impute the nursing technician, but chose not to request her arrest “at least for the moment” because she has no criminal record and has a known address, among other reasons, according to the G1 news portal.

The nursing technician participated in the immunization campaign against Covid-19, but at the time of applying the dose to an elderly man, she pretended to do so, the syringe only contained air; the old man’s family discovered it when they got home and reviewed the video they recorded with their cell phone.

When questioned by the civil police, the accused alleged that she was “extremely tired and stressed.”

The Prosecutor’s Office requested his provisional imprisonment, understanding that his freedom endangers public health.

At the moment, she was fired from the Niteroi Municipal Health Secretariat where she worked, and the judge decided this Monday that she appear every month before the Justice until the trial is carried out.

In recent weeks, several cases of false vaccination were detected in Brazil, at least in the cities of Rio de Janeiro (southeast), São Paulo (southeast), Goiânia (center-west) and Maceió (northeast).

.

La Jornada – 7 countries hoard half of the Covid vaccines available

Paris. More than 200 million doses of Covid-19 vaccines were administered in 107 countries and territories, and 45 percent were injected in the rich G-7 countries, despite the fact that they only house 10 percent of the world’s population, according to an Afp count from official sources.

Until Saturday, a total of 201 million 42 thousand 149 administered doses were registered. But this figure is lower than the real one, since Russia and China have not communicated their official figures for ten days.

The G-7 countries announced on Friday their commitment in favor of a better distribution with poor countries, doubling their support for vaccination, which will reach 7.5 billion dollars, mainly through the Covax program, managed by the World Health Organization (WHO), which seeks to get enough injections to nations with fewer resources.

Still, the humanitarian agency Oxfam accused wealthy countries of giving “leftovers” of their vaccines to developing nations.

But right now, nine out of ten vaccines are injected in high- or medium-high-resource countries, according to the World Bank, and nearly half in the G-7.

In contrast, of the 29 “weak” income countries, only Guinea and Rwanda have started to inoculate. Some 1,840 million people – almost a quarter of the world’s population – live in nations that have not yet vaccinated. The United States, Canada, and European countries represent more than 68 million of the 110 million infections in the world.

In terms of death toll, the United States exceeds 495 thousand, well ahead of the second country on the list, Brazil (more than 244 thousand deaths). Europe adds more than 825 thousand deaths, followed by Latin America and the Caribbean, with more than 655 thousand.

“No country will be safe until all are,” the Organization of American States (OAS) warned this week in a resolution approved by acclamation by its Permanent Council, which brings together 34 active members.

The initiative, presented by the countries of the Caribbean Community (Caricom) and co-sponsored by Argentina, Mexico, Nicaragua, Panama and Uruguay, among others, highlights that defeating the virus in a “sustainable” way around the planet will depend “on the distribution of vaccines for all ”.

With 9 million inhabitants, Israel is the most advanced country in vaccination, with 49 percent of its population having received at least one dose of the vaccine. At this time, one in three inhabitants of that country (33 percent) has received the two necessary doses.

The infection rate in Israel fell 95.8 percent among people who received two doses of the biological from Pfizer, the Ministry of Health of that country reported yesterday. Tel Aviv this week blocked the passage of 2,000 doses of the Sputnik V vaccine that the Palestinians hoped to immunize their medical personnel in the Gaza Strip, the most densely populated territory in the world, where 53,000 cases and 538 deaths have been registered. .

Other countries have exceeded 10 percent of the inoculated population. These are the United Kingdom (25 percent), Bahrain (16 percent), the United States (13 percent), Chile (12 percent) and the Maldives (12 percent). In absolute numbers, the United States is the country that has injected the most drugs (59.6 million doses), ahead of China (40.5 million until February 9), the United Kingdom (17.5 million), India (10.7 million) and Israel ( 7.1 million).

Russia has approved CoviVac, its third vaccine, Prime Minister Mikhail Mishustin reported, although large-scale clinical trials of the injection, produced by the Chumakov Center, have not yet begun.

All adults in Britain will be offered a first injection at the end of July, Prime Minister Boris Johnson said.

Britain sent a draft resolution to the United Nations Security Council calling for all parties to major conflicts in the world to immediately decree a “sustained humanitarian pause” to allow people in war zones to be vaccinated. .

Brazil registered 51 thousand 50 new confirmed cases, with which its national accumulated already exceeded 10 million. In that country they denounced on social networks the application of “air vaccines” to older adults.

Three videos, filmed in different states, showed that health professionals inserted needles in patients, but did not inject the dose against Covid-19 and even in one case they injected air into a woman.

The pandemic has left 111 million 32 thousand 169 confirmed cases, 2 million 459 thousand 49 deaths and 62 million 573 thousand 467 recovered, according to the Johns Hopkins University count.

.

La Jornada – Poor countries are forced to wait for “vaccine leftovers” Covid: Oxfam

Brussels. The international organization against poverty Oxfam accused yesterday that the world’s largest economies are forcing poor nations to wait for “leftovers” of vaccines, after the G-7 group of powers announced new contributions in the battle against coronavirus.

With a commitment of up to $ 4 billion from the President of the United States, Joe Biden, and a doubling of contributions from the European Union (EU) to reach up to $ 1.2 billion, the collective support of the G-7 for the Covax international biological fund reached 7.5 billion dollars.

British Prime Minister Boris Johnson, who chaired the virtual summit, promised to donate most of the UK’s surplus injections to the developing world, telling his fellow leaders that it was “pointless” to inoculate his own populations while letting the coronavirus will spread and mutate elsewhere.

However, Oxfam’s head of inequality policy, Max Lawson, warned that the measures, while welcome, were “insufficient compared to the scale of the Covid-19 threat.

“Making large parts of Africa and Asia wait for leftover and unwanted vaccines from the stocks of rich countries is not only immoral, it is irresponsible. The lack of coordinated action by the G-7 is unforgivable, ”Lawson said.

“The longer protection is denied to large swaths of the world’s population, the greater the threat that virus mutations threaten us all.”

Calling on rich countries to remove pharmaceutical companies’ control over immunologicals, Lawson added: “Among them, the G-7 nations have secured enough vaccines for each of their citizens to be inoculated three times, while many countries poor people should still receive single dose.

“Rather than pat itself on the back for limited progress, the best the G-7 could do would be to stop supporting its pharmaceutical corporations’ monopolies on Covid-19 vaccines,” he noted.

At the summit, the president of the European Commission, Ursula von der Leyen, announced that the EU will double its contribution to the Covax mechanism to reach 1.2 billion dollars. In addition, the block will provide a contribution of 121.4 million dollars to support inoculation campaigns in Africa.

Biden announced at that meeting a $ 4 billion contribution to Covax, while calling on the G-7 to honor its commitment to the platform.

The funding includes an initial contribution of 2 billion that the US Congress appropriated in December. Biden will award another 2 billion during 2021 and 2022.

For its part, Germany announced that it will contribute an additional 1.8 billion dollars to the global fight against the pandemic.

Led by the World Health Organization (WHO), the Covax program plans to distribute Covid-19 vaccines to 20 percent of the population in nearly 200 countries and territories this year, and includes a funding mechanism for 92 economies low and middle income people can access immunizers.

The US company Novavax has committed to making a total of 1.1 billion doses of its biologic available to the Covax program, the Vaccine Alliance reported.

Effectiveness

The first injection of Pfizer-BioNTech is 85 percent effective two to four weeks after administration, according to a journal study The Lancet, applied to staff of the largest hospital in Israel.

AstraZeneca’s immunological and Oxford University is more effective if the second dose is given three months after the first instead of six weeks, a study also published in The Lancet.

The WHO indicated that the reduction of confirmed cases in Europe provides a breathing space to assess responses to the pandemic and strengthen health systems.

In the United States, with 495,000 deaths and 27 million cases, the White House contacted social media companies, including Facebook, to clamp down on misinformation about the coronavirus.

The pandemic has left 110 million 658 thousand 952 confirmed cases, 2 million 450 thousand 462 deaths and 62 million 314 thousand 773 recovered in the world, according to Johns Hopkins University.

.

La Jornada – Poor countries are forced to wait for “vaccine leftovers” Covid: Oxfam

Brussels. The international organization against poverty Oxfam accused yesterday that the world’s largest economies are forcing poor nations to wait for “leftovers” of vaccines, after the G-7 group of powers announced new contributions in the battle against coronavirus.

With a commitment of up to $ 4 billion from the President of the United States, Joe Biden, and a doubling of contributions from the European Union (EU) to reach up to $ 1.2 billion, the collective support of the G-7 for the Covax international biological fund reached 7.5 billion dollars.

British Prime Minister Boris Johnson, who chaired the virtual summit, promised to donate most of the UK’s surplus injections to the developing world, telling his fellow leaders that it was “pointless” to inoculate his own populations while letting the coronavirus will spread and mutate elsewhere.

However, Oxfam’s head of inequality policy, Max Lawson, warned that the measures, while welcome, were “insufficient compared to the scale of the Covid-19 threat.

“Making large parts of Africa and Asia wait for leftover and unwanted vaccines from the stocks of rich countries is not only immoral, it is irresponsible. The lack of coordinated action by the G-7 is unforgivable, ”Lawson said.

“The longer protection is denied to large swaths of the world’s population, the greater the threat that virus mutations threaten us all.”

Calling on rich countries to remove pharmaceutical companies’ control over immunologicals, Lawson added: “Among them, the G-7 nations have secured enough vaccines for each of their citizens to be inoculated three times, while many countries poor people should still receive single dose.

“Rather than pat itself on the back for limited progress, the best the G-7 could do would be to stop supporting its pharmaceutical corporations’ monopolies on Covid-19 vaccines,” he noted.

At the summit, the president of the European Commission, Ursula von der Leyen, announced that the EU will double its contribution to the Covax mechanism to reach 1.2 billion dollars. In addition, the block will provide a contribution of 121.4 million dollars to support inoculation campaigns in Africa.

Biden announced at that meeting a $ 4 billion contribution to Covax, while calling on the G-7 to honor its commitment to the platform.

The funding includes an initial contribution of 2 billion that the US Congress appropriated in December. Biden will award another 2 billion during 2021 and 2022.

For its part, Germany announced that it will contribute an additional 1.8 billion dollars to the global fight against the pandemic.

Led by the World Health Organization (WHO), the Covax program plans to distribute Covid-19 vaccines to 20 percent of the population in nearly 200 countries and territories this year, and includes a funding mechanism for 92 economies low and middle income people can access immunizers.

The US company Novavax has committed to making a total of 1.1 billion doses of its biologic available to the Covax program, the Vaccine Alliance reported.

Effectiveness

The first injection of Pfizer-BioNTech is 85 percent effective two to four weeks after administration, according to a journal study The Lancet, applied to staff of the largest hospital in Israel.

AstraZeneca’s immunological and Oxford University is more effective if the second dose is given three months after the first instead of six weeks, a study also published in The Lancet.

The WHO indicated that the reduction of confirmed cases in Europe provides a breathing space to assess responses to the pandemic and strengthen health systems.

In the United States, with 495,000 deaths and 27 million cases, the White House contacted social media companies, including Facebook, to clamp down on misinformation about the coronavirus.

The pandemic has left 110 million 658 thousand 952 confirmed cases, 2 million 450 thousand 462 deaths and 62 million 314 thousand 773 recovered in the world, according to Johns Hopkins University.

.

Coronavirus: Janssen, CureVac and Novavax, the Covid-19 vaccines arriving soon | Companies

The acceleration in the vaccination process in Europe will come from spring thanks to the expected greater industrial capacity of the current suppliers – Pfizer / BioNTech, AstraZeneca and Moderna – but also due to the imminent arrival of new alternatives, especially that of Janssen ( Johnson & Johnson group), which Europe could approve in mid-March. The use of the Novavax and CureVac options is also expected for the second quarter. The objective of the European Commission is that by September 21, 70% of the continent’s population (herd immunity) is vaccinated.

The next vaccine expected to arrive will be Janssen’s, currently in an experimental phase in phase III clinical trials (being tested on thousands of volunteers and before applying for marketing authorization). Since December 1, the European Medicines Agency (EMA) has been evaluating this candidate based on adenovirus. This community body is expected to endorse its use in mid-March, which would guarantee its distribution in the EU that same month.

The European Commission has agreed with the US giant to purchase 200 million doses, plus an additional 200 million. For Spain, the total would be 42 million doses. Its estimated price, according to Reuters, could be 8.5 euros, although the agreements of these manufacturers with Brussels are confidential.

The approval of the Janssen option, which in clinical studies has shown an efficacy of 66%, would also facilitate the rapid advance of vaccination plans, because it is the only antigen that is administered in a single injection.

Deutsche Bank estimates that Janssen could supply significantly from April in Europe and 20 million doses a month from June, around 2.1 million for Spain, which would facilitate herd immunity by the end of summer.

In European production, Janssen will rely on the new plant for injectable products at the Catalan Reig Jofre laboratory in Sant Joan Despí (Barcelona), which plans to start manufacturing this first quarter.

Second quarter

Probably, after Janssen’s version of the American Novavax, in phase III of investigation, would arrive. Since February 12, the EMA has continuously reviewed this product based on protein S fragments. In clinical studies, it has shown an efficacy of 89% after the administration of the second dose.

“We hope to apply for a marketing authorization after our phase III trial in the UK is completed,” responds a Novavax spokesperson on the request for distribution in Europe, “which we anticipate will be in approximately two to two and a half months” When the spring has advanced. “And if it is approved, doses will begin to be distributed at the earliest in the second trimester,” he said.

At the moment, the European Commission has not closed the purchase of Novavax, although there is a prior agreement to purchase 100 million injections (plus 100 million optional), which would mean a maximum of 21 million doses for the autonomous communities.

This biotechnology firm also has a Spanish partner, the Galician group Zendal, which through its subsidiary Biofabri will produce the antigen in O Porriño (Pontevedra).

The arrival of the CureVac product is expected in similar terms. Since February 12, the EMA has been evaluating the experimental product based on messenger RNA (such as those from BioNTech / Pfizer and Moderna) from the German biotech. The company expects to present the efficacy studies later this quarter and for distribution to arrive in the second quarter.

Brussels has acquired 405 million doses from this laboratory, which has the German State as a shareholder, of which a maximum of 42 million would reach Spain. This company recently partnered with German giant Bayer to accelerate trials, improve distribution and increase industrial capacity.

.

+ Coronavirus today: New Zealand begins its vaccination campaign + | The World | DW

All updates in Central European Time (CET).

10:17 | Russia registers a third vaccine, the CoviVac

Russia has registered its third vaccine against COVID-19, prior to the final phase of clinical trials, Prime Minister Mikhail Mishustin announced this Saturday. “Starting in mid-March, the first 120,000 doses will be available. Russia is today the only country that has three vaccines,” he said.

Christened Kovivak (CoviVac), this third vaccine was manufactured by the Shumakov Research Center in Moscow. Unlike the first two vaccines, this one uses an inactivated virus, a more traditional technology. Russia has already registered the Sputnik V vaccine in August and EpiVacCorona in October, and is vaccinating its population.

08:45 | New Zealand begins its vaccination campaign

New Zealand began its vaccination campaign this Saturday with the injection of the pharmaceutical company Pfizer. The first vaccines were administered the day before to 29 health workers, who are now in charge of inoculating workers at the border posts.

“Our COVID-19 vaccination program begins! We started with our front-line workers at the borders, the ones who have kept us safe for a long time,” Prime Minister Jacinda Ardern announced on her Facebook account.

08:29 | Government of the Netherlands passes alternative law to maintain curfew

The Dutch government will be able to maintain the curfew from this Saturday with an alternative law endorsed by Parliament and the Senate, while the courts study the legitimacy of the legal basis used so far to apply the restriction.

The government is now awaiting the outcome of the appeal it filed against the ruling that demands the suspension of the restriction, but the Justice allows it to maintain the curfew in the meantime until it decides on Friday whether or not it has a correct legal basis in that law of emergencies.

08:11 | Germany registers more than 9,000 new cases

The new infections rose in Germany in relation to last week, as well as the cumulative incidence compared to yesterday, while the reproduction factor is again above 1.

It is about 9,164 new infections in the last 24 hours, compared to 8,354 last Saturday, according to the German authority on diseases, the Robert Koch Institute (RKI). 490 fatalities were also registered. In total, 67,696 people have died of COVID-19 in the country and 2,378,883 have been infected.

afp / reuters / ap / dpa / rki / efe // rr

.

Two women dress up as grandmothers to receive the covid-19 vaccine – US and Canada – International


US media ABC reported that two women disguised themselves as “grandmothers” in an unsuccessful attempt to obtain a second dose of the COVID-19 vaccine, Florida health officials said.

(As well: G7 meeting: Biden calls for tackling China’s ‘economic abuses’)

Yesterday we realized that a couple of young ladies came disguised as grandmothers to get vaccinated for the second time“Dr. Raul Pino, director of the Florida Department of Health in Orange County, told ABC Thursday during a news conference.

The women showed up at the Orange County Convention Center wearing hats, gloves and glasses, “everything,” Pino said. They are between 30 and 40 years old, according to the Orange County Sheriff’s Office, which would make them ineligible to receive the vaccine outside of a medical or long-term care facility.

(Lea: US formally offers to restart negotiations with Iran)

They both had valid vaccination cards from their first vaccination, but on their second attempt, there were problems with their driver’s licensessaid Pino.

Agents issued the two women illegal trespassing warnings after their birth dates “did not match the ones they used to register for vaccinations“The Orange County Sheriff’s Office said in a statement.” The names, however, matched the record. “

The sheriff’s office identified the women as Olga Monroy-Ramirez, 44, and Martha Vivian Monroy, 34.

Last month, Florida began requiring proof of residency for COVID-19 vaccines following concerns about “vaccine tourism” d

No further law enforcement action was taken, the sheriff’s office said, adding: “And we don’t have any information on whether they were in costume or how they were dressed.”

There have been a few cases of people misrepresenting themselves for a dose, Pino said, adding that it is probably “higher than we suspect“.

(Follow with: Who will benefit from the immigration reform project in the United States?)

Beyond healthcare workers and residents and staff at long-term care facilities, people 65 and older are eligible to get the vaccine in Florida. Nearly 45% of that population has been vaccinated in Orange County, authorities said Thursday.

Last month, Florida began requiring proof of residency for COVID-19 vaccines in select counties following concerns about the “vaccine tourism“after eligibility was opened to anyone 65 years of age or older.

(What’s more: The crisis in Texas due to power cuts in the middle of winter)

DRAFTING THE TIME

.

Covid: they will test the Sputnik V vaccine in the form of nasal drops – Europe – International


In Moscow, Russia, a three-phase investigation will begin to develop a nasal form of Sputnik V, the vaccine developed by that country against COVID-19.

The announcement was made by Sergey Sobianin, mayor of the Russian capital, through a February 17 post on his personal blog.

The president said that this new way of immunization does not replace complete vaccination, but it can be very useful as an additional form of protection.

According to an anonymous source related to the research who spoke to Forbes magazine, the original vaccine can prevent the disease from entering a critical stage and prevent pneumonia, but it cannot prevent a person from being a carrier of the virus. “The person may not even notice the infection, but it will be its carrier for several days,” he explained.

(You may be interested: Pfizer and Moderna vaccines could protect against new variants).

On the contrary, if it is administered through the nose, “in addition to protecting the lower respiratory tract, the lungs, etc., the first line of defense will be formed: the immunity of the mucous membranes,” added the source.

If this method goes on the market successfully, it would be essential in case the vaccine needs to be given a second time.

A possibility that is already being considered, as Mayor Sobianin said that immunization is being evaluated in the vaccinated population, to determine if a revaccination is needed in the second period of 2021.

The Sputnik V vaccine is 92% effective.

Photo:

Kirill Kudryavtsev. AFP

(Read on: Russia acknowledges that it has no capacity to meet demand for Sputnik V.)

According to the president, monitoring is being carried out every month to measure the evolution of the vaccine in the body. If they notice that immunity wanes after 9 or 10 months, a second vaccination plan will be needed.

The expert interviewed by ‘Forbes’ said that this second immunization cycle would not be as effective as the first, because the immune system will not only create antibodies against covid-19, but also against the formula used in the vaccine.

With the application of nasal immunization this problem would be avoided, since the formula would not come into contact with the antibodies.

The expert also added that it would become the ideal method to vaccinate children because, although most do not get seriously ill, they can be silent carriers.

(You can read: To what does science attribute the global decline in covid-19 cases?).

Trends WEATHER

.

+ Coronavirus today: Africa exceeds 100,000 deaths from COVID-19 + | The World | DW

All updates in Central European Time (CET).

11:14 | Israeli study shows a dose of Pfizer reduces infections by 85%

A study from the Israeli Sheba hospital, released this Friday and published in the scientific journal The Lancet, showed that the first dose of the vaccine produced by Pfizer reduced infections 75% at least two weeks after its administration

The first dose of Pfizer is also 85% effective, potentially sparking debate over the recommended two-dose schedule as governments try to lengthen supplies. This study is the first in Israel and one of the first in the world on the efficacy of the first dose of Pfizer’s vaccine.

11:10 | UE will double its contribution to the Covax vaccine program

The European Union will announce during the G7 meeting on Friday that it doubles its contribution to the Covax program, aimed at supplying vaccines to countries with few resources, to reach 1 billion euros, said a European source.

The president of the European Commission, Ursula von der Leyen, will also announce during that summit a contribution of 100 million euros to support the vaccination campaign in Africa, according to the same source.

09:34 | German Teachers Association calls for caution in reopening schools

Mutations, of which the British one already represents 22% of infections in Germany, is “the greatest threat to a clear, reliable and sustainable prospect of reopening schools,” said the president of the German Association of Teachers, Heinz- Peter Meidinger.

In his opinion, face-to-face classes should be allowed only from a cumulative incidence below 35 new infections per 100,000 inhabitants in seven days.

09:06 | Africa surpasses 100,000 deaths from COVID-19

Africa surpassed the barrier of 100,000 deaths from COVID-19 on Friday, as the continent faces a second wave of the disease and tries to accelerate the deployment of vaccines, the Centers for Disease Control and Prevention of Africa (Africa CDC) reported. .

Since the first continental contagion was detected, on February 14, 2020 in Egypt, the 55 member countries of the African Union accumulate 100,294 deaths (4% of the world total). The region has registered 3.79 million infections (3.5% of the world total).

07:51 | Renault registers historic loss due to pandemic

The French car manufacturer Renault recorded a historic loss of 8,000 million euros in 2020, marked by the coronavirus crisis, announced this Friday in a statement.

The group limited the damage in the second half with a decline in turnover of only 8.9% and 660 million euros. But its annual figures remain on the ground, weighed down by the drop in sales (-21.3%) and the results of its Japanese partner Nissan.

afp / reuters / ap / dpa / epd / efe // rr

.